Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis Nederland - OncologieNovartis Nederland - Oncologie
VS
CiplaCipla
Novartis Nederland - Oncologie

Novartis Nederland - Oncologie

Haaksbergweg 16, Amsterdam, 1101 BX, NL

Last Update: 04/04/2026

View Profile

Novartis Oncologie ontwikkelt een portfolio met gepatenteerde geneesmiddelen op het gebied van oncologie, hematologie en zeldzame aandoeningen om mensen met kanker en aanverwante ziekten zo goed mogelijk te behandelen. De richtlijnen van onze LinkedIn pagina kan je ter...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:43
12-month incidents
0
Known data breaches
0
Attack type number
0
Cipla

Cipla

Lower Parel, Ganpatrao Kadam Marg,, Mumbai, Maharashtra, IN, 400013

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.cipla.com
782/1000Fair

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:50,326
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Nederland - Oncologie

Novartis Nederland - Oncologie

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Cipla

Cipla

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Nederland - Oncologie in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Cipla in 2026.

Incidents

Incident History - Novartis Nederland - Oncologie (X = Date, Y = Severity)

Novartis Nederland - Oncologie cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Cipla (X = Date, Y = Severity)

Cipla cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Nederland - Oncologie

Novartis Nederland - Oncologie

Incidents
No explicit notable incidents reported.
Cipla

Cipla

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Nederland - Oncologie company and Cipla company, which one has the best AI Cybersecurity Score ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced more cyber incidents in the past ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced more cyber incidents this year ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced at least one ransomware attack ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced at least one data breach ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced at least one targeted cyberattack ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has experienced at least one vulnerability ?
Between Novartis Nederland - Oncologie company and Cipla company, which one holds the most compliance certifications ?
Between Novartis Nederland - Oncologie company and Cipla company, which one holds the fewest compliance certifications ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has the most subsidiaries ?
Between Novartis Nederland - Oncologie company and Cipla company, which one has the largest number of employees ?
Between Novartis Nederland - Oncologie and Cipla, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Nederland - Oncologie and Cipla, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Nederland - Oncologie or Cipla ?
Which company is PCI DSS compliant - Novartis Nederland - Oncologie or Cipla ?
Between Novartis Nederland - Oncologie and Cipla, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Nederland - Oncologie and Cipla, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-66473
SUMMARY

Unauthenticated Broken Access Control in Xendit Payment <= 7.1.0 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-65448
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Anti Spam and list cleaner &#8211; AcyChecker <= 1.8.1 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.3
CVE-2026-65447
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Contest Gallery <= 30.0.6 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
CVE-2026-65446
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Kali Forms <= 2.4.18 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
CVE-2026-65445
SUMMARY

Unauthenticated Broken Access Control in Ad Invalid Click Protector (AICP) <= 1.3.0 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L
IMPACT SCORE
2.5
EXPLOITABILITY
3.9